Aurum Biosciences Raise £730k in Fresh Investment

Jan 31, 2024•almost 2 years ago

Amount Raised

£730,000

Round Type

seed

GlasgowBiotechnology Research

Investors

Tricapital Business Angel SyndicateScottish EnterpriseInno Scot HealthDr Celestine Santosh

Description

Aurum Biosciences has raised almost £730,000 in the first tranche of a new round of equity funding to further develop its therapeutic and diagnostic technology.

Company Information

Company

Aurum Biosciences

Location

Glasgow, Kentucky, United States

About

Aurum Biosciences Ltd is a clinical stage biopharmaceutical company developing novel oxygen carriers for use as therapeutics and diagnostics, initially for Acute Ischaemic Stroke (AIS). Follow-on indications include heart disease, oncology, inflammatory conditions, spinal cord injury, and dementia. Preclinical development has been completed in the lead indication (AIS) and approval has been granted to initiate clinical studies in acute stroke patients. Concurrently, Aurum is pursuing opportunities to develop its pipeline indications with a focus on inflammatory conditions and oncology.

Related People

2 contacts

Funding Insights

Based on industry data

VC-backed spending patterns

VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

Tech investment trends